O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia.
Authors
Graziani, GFaraoni, I
Grohmann, U
Bianchi, R
Binaglia, L
Margison, Geoffrey P
Watson, Amanda J
Orlando, L
Bonmassar, E
D'Atri, S
Affiliation
Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, Italy.Issue Date
1995-12-15
Metadata
Show full item recordAbstract
Methylating and chloroethylating triazene compounds (TZCs) are effective antitumor agents in murine leukemias and can induce the appearance of novel antigens in leukemic cells (chemical xenogenization). Recently, it has been shown that TZCs might have a role in the treatment of patients affected by acute myelogenous leukemias that express low levels of the DNA repair enzyme, O6-alkylguanine-DNA alkyltransferase (OGAT). In this report, we have evaluated the role of this DNA repair enzyme in the leukemic cell response to the xenogenizing and cytotoxic properties of TZCs. OGAT-deficient murine leukemic L1210 cells were transfected with a recombinant ecotropic retrovirus containing the coding region for the human OGAT protein. Selected clones expressed the human OGAT transcript and had greatly increased OGAT activity. Compared to OGAT-deficient cells, OGAT-expressing cells were considerably more resistant to the xenogenizing properties of 1-(p-chlorophenyl)-3,3- dimethyl-triazene, measured in terms of leukemia graft rejection, and were less susceptible to the cytotoxic activity of the TZCs 8-carbamoyl-3-methyl-imidazo [5,1-d]-1,2,3,5-tetrazin-4(3H)-one and 8-carbamoyl-3-(2-chloroethyl)imidazo [5,1-d]-1,2,3,5-tetrazin-4(3H)-one. These data suggest that methylation of the O6 position of guanine is involved in the appearance of increased tumor immunogenicity after exposure to methylating TZC and that OGAT is able, at least in part, to counteract the cytotoxic effects of methylating and chloroethylating agents.Citation
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia. 1995, 55 (24):6231-6 Cancer Res.Journal
Cancer ResearchPubMed ID
8521419Type
ArticleLanguage
enISSN
0008-5472Collections
Related articles
- In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds.
- Authors: Lacal PM, D'Atri S, Orlando L, Bonmassar E, Graziani G
- Issue date: 1996 Oct
- Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines.
- Authors: Tentori L, Graziani G, Gilberti S, Lacal PM, Bonmassar E, D'Atri S
- Issue date: 1995 Nov
- Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.
- Authors: Tentori L, Orlando L, Lacal PM, Benincasa E, Faraoni I, Bonmassar E, D'Atri S, Graziani G
- Issue date: 1997 Aug
- O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents.
- Authors: Bianchi R, Citti L, Beghetti R, Romani L, D'Incalci M, Puccetti P, Fioretti MC
- Issue date: 1992
- Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase.
- Authors: Tentori L, Lacal PM, Benincasa E, Franco D, Faraoni I, Bonmassar E, Graziani G
- Issue date: 1998 May